Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026)

Regeneron Pharmaceuticals (REGN) recorded quarterly Dividends Paid - Common of $97.8 million in Q1 2026, up 5.5% quarter-over-quarter from $92.7 million in Q4 2025, and up 4.26% on a YoY basis from $93.8 million in Q1 2025.

Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026) Analysis & Trends

Regeneron Pharmaceuticals' Dividends Paid - Common history runs 2 years deep, the most recent figure standing at $97.8 million for Q1 2026.

  • In Q1 2026, Dividends Paid - Common rose 4.26% year-over-year to $97.8 million; the TTM figure through Mar 2026 stood at $374.3 million (up 299.04% YoY), while the FY2025 annual figure was $370.3 million, changed N/A from the prior year.
  • Dividends Paid - Common was $97.8 million for Q1 2026 at Regeneron Pharmaceuticals, up from $92.7 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $97.8 million in Q1 2026 to a low of $91.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Regeneron Pharmaceuticals 63.59 Bn 54.83 Bn 3.31 Bn 97.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 97.80 Mn
Mar 31, 2026 97.80 Mn
Dec 31, 2025 92.70 Mn
Dec 31, 2025 92.70 Mn
Sep 30, 2025 91.20 Mn
Sep 30, 2025 91.20 Mn
Jun 30, 2025 92.60 Mn
Jun 30, 2025 92.60 Mn
Mar 31, 2025 93.80 Mn
Mar 31, 2025 93.80 Mn